In this edition of The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS), held December 10 – 14, 2019 in San Antonio, Texas, Peter Hofland talks with leading breast cancer experts, and patients about metastatic breast cancer and health related quality of life hrQoL issues including sexual intimacy, bone health and joint pain. In this roundtable, panelists will also discuss liquid biomarkers for disease progression in the metastatic setting.

The expert panel includes;

– David Portman, MD, founder and Chief Executive Officer (CEO) of Sermonix Pharmaceuticals. Portman is a respected Key Opinion Leader (KOL) in the field, presented clinical data at national and international conferences, and published dozens of peer-reviewed papers in the field of menopause, VVA, SERMs and sexual health. Before founding Sermonix in 2014, Portman was founder and director of the Columbus Center for Women’s Health Research for 18 years where he conducted over 140 clinical trials in women’s health. He received his BA from Northwestern University and his MD and Obstetric and Gynecology residency from The Ohio State University College of Medicine where he is an adjunct instructor.

– Kelli Davis, metastatic breast cancer patient and director of social media at Metavivor. Davis, is an outspoken advocate on behalf of women living with the disease, was diagnosed with stage I breast cancer in 2009 and stage IIIc in 2013. She learned she had stage IV, or metastatic, breast cancer in late 2014.

– Stephanie L. Graff, MD, director of the Breast Cancer Program at Sarah Cannon Cancer Institute at HCA Midwest Health and associate director of the Breast Cancer Research Program at Sarah Cannon Research Institute. Graff, an award-winning writer and social media influencer, has broad experience as a principal investigator on numerous clinical trials. She received the Frist Humanitarian Award for her work improving the lives of people in her healthcare community, and serves on the boards of the American Cancer Society Kansas/Kansas City Area and The Research Foundation.

– Kelly Shanahan, MD, an Ob/Gyn, Metavivor board member, metastatic breast cancer patient and advocate. Shanahan is a wife, a mother, a daughter, a doctor, a woman living with metastatic breast cancer. She is also an outspoken advocate. Metastatic breast cancer stole her career and through the horrible diagnosis, she was introduced to amazing women and men who showed her that she, as a trained physician, could still help others and make a difference through advocacy.